Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2026-06-04 @ 10:00 AM
Study NCT ID:
NCT00082095
Status:
TERMINATED
Last Update Posted:
2014-10-09
First Post:
2004-04-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older
Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |